-
Je něco špatně v tomto záznamu ?
Swedish Alzheimer's disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways
M. Feole, VM. Pozo Devoto, N. Dragišić, C. Arnaiz, J. Bianchelli, K. Texlová, K. Kovačovicova, JS. Novotny, D. Havas, TL. Falzone, GB. Stokin
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2021
PubMed Central
od 2005
Open Access Digital Library
od 1905-10-01
Open Access Digital Library
od 1905-10-01
Elsevier Open Access Journals
od 1905-10-01
ROAD: Directory of Open Access Scholarly Resources
od 1905
- MeSH
- Alzheimerova nemoc * metabolismus genetika patologie MeSH
- amyloidový prekurzorový protein beta * genetika metabolismus MeSH
- axonální transport * genetika MeSH
- axony metabolismus patologie MeSH
- dynaktinový komplex metabolismus genetika MeSH
- dyneiny metabolismus MeSH
- endozomy metabolismus genetika MeSH
- genetická variace MeSH
- lidé MeSH
- lyzozomy metabolismus MeSH
- mutace MeSH
- myši MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Experimental studies in flies, mice, and humans suggest a significant role of impaired axonal transport in the pathogenesis of Alzheimer's disease (AD). The mechanisms underlying these impairments in axonal transport, however, remain poorly understood. Here we report that the Swedish familial AD mutation causes a standstill of the amyloid precursor protein (APP) in the axons at the expense of its reduced anterograde transport. The standstill reflects the perturbed directionality of the axonal transport of APP, which spends significantly more time traveling in the retrograde direction. This ineffective movement is accompanied by an enhanced association of dynactin-1 with APP, which suggests that reduced anterograde transport of APP is the result of enhanced activation of the retrograde molecular motor dynein by dynactin-1. The impact of the Swedish mutation on axonal transport is not limited to the APP vesicles since it also reverses the directionality of a subset of early endosomes, which become enlarged and aberrantly accumulate in distal locations. In addition, it also reduces the trafficking of lysosomes due to their less effective retrograde movement. Altogether, our experiments suggest a pivotal involvement of retrograde molecular motors and transport in the mechanisms underlying impaired axonal transport in AD and reveal significantly more widespread derangement of axonal transport pathways in the pathogenesis of AD.
Department of Neurosciences Mayo Clinic Rochester Minnesota USA
Division of Neurology University Medical Centre Ljubljana Slovenia
Faculty of Medicine Department of Biology Masaryk University Brno Czech Republic
PsychoGenics Paramus New Jersey USA
School of Cardiovascular and Metabolic Medicine and Sciences King's College London London UK
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014452
- 003
- CZ-PrNML
- 005
- 20240905133437.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jbc.2024.107137 $2 doi
- 035 __
- $a (PubMed)38447793
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Feole, Monica $u Translational Ageing and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre, St Anne's University Hospital, Brno, Czech Republic; Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic; School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK
- 245 10
- $a Swedish Alzheimer's disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways / $c M. Feole, VM. Pozo Devoto, N. Dragišić, C. Arnaiz, J. Bianchelli, K. Texlová, K. Kovačovicova, JS. Novotny, D. Havas, TL. Falzone, GB. Stokin
- 520 9_
- $a Experimental studies in flies, mice, and humans suggest a significant role of impaired axonal transport in the pathogenesis of Alzheimer's disease (AD). The mechanisms underlying these impairments in axonal transport, however, remain poorly understood. Here we report that the Swedish familial AD mutation causes a standstill of the amyloid precursor protein (APP) in the axons at the expense of its reduced anterograde transport. The standstill reflects the perturbed directionality of the axonal transport of APP, which spends significantly more time traveling in the retrograde direction. This ineffective movement is accompanied by an enhanced association of dynactin-1 with APP, which suggests that reduced anterograde transport of APP is the result of enhanced activation of the retrograde molecular motor dynein by dynactin-1. The impact of the Swedish mutation on axonal transport is not limited to the APP vesicles since it also reverses the directionality of a subset of early endosomes, which become enlarged and aberrantly accumulate in distal locations. In addition, it also reduces the trafficking of lysosomes due to their less effective retrograde movement. Altogether, our experiments suggest a pivotal involvement of retrograde molecular motors and transport in the mechanisms underlying impaired axonal transport in AD and reveal significantly more widespread derangement of axonal transport pathways in the pathogenesis of AD.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 12
- $a Alzheimerova nemoc $x metabolismus $x genetika $x patologie $7 D000544
- 650 12
- $a amyloidový prekurzorový protein beta $x genetika $x metabolismus $7 D016564
- 650 12
- $a axonální transport $x genetika $7 D001370
- 650 _2
- $a axony $x metabolismus $x patologie $7 D001369
- 650 _2
- $a dynaktinový komplex $x metabolismus $x genetika $7 D000072159
- 650 _2
- $a dyneiny $x metabolismus $7 D004398
- 650 _2
- $a endozomy $x metabolismus $x genetika $7 D011992
- 650 _2
- $a lyzozomy $x metabolismus $7 D008247
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a genetická variace $7 D014644
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pozo Devoto, Victorio M $u Translational Ageing and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre, St Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Dragišić, Neda $u Translational Ageing and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre, St Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Arnaiz, Cayetana $u Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA-CONICET-MPSP), Partner Institute of the Max Planck Society, Buenos Aires, Argentina
- 700 1_
- $a Bianchelli, Julieta $u Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA-CONICET-MPSP), Partner Institute of the Max Planck Society, Buenos Aires, Argentina
- 700 1_
- $a Texlová, Kateřina $u Translational Ageing and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre, St Anne's University Hospital, Brno, Czech Republic; PsychoGenics, Paramus, New Jersey, USA
- 700 1_
- $a Kovačovicova, Kristina $u PsychoGenics, Paramus, New Jersey, USA
- 700 1_
- $a Novotny, Jan S $u Translational Ageing and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre, St Anne's University Hospital, Brno, Czech Republic; Institute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Havas, Daniel $u PsychoGenics, Paramus, New Jersey, USA
- 700 1_
- $a Falzone, Tomas L $u Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA-CONICET-MPSP), Partner Institute of the Max Planck Society, Buenos Aires, Argentina; Instituto de Biología Celular y Neurociencia IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
- 700 1_
- $a Stokin, Gorazd B $u Translational Ageing and Neuroscience Program, Centre for Translational Medicine, International Clinical Research Centre, St Anne's University Hospital, Brno, Czech Republic; Institute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic; Division of Neurology, University Medical Centre, Ljubljana, Slovenia; Department of Neurosciences, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: gbstokin@alumni.ucsd.edu
- 773 0_
- $w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 300, č. 4 (2024), s. 107137
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38447793 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133431 $b ABA008
- 999 __
- $a ok $b bmc $g 2143920 $s 1226318
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 300 $c 4 $d 107137 $e 20240305 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
- LZP __
- $a Pubmed-20240725